申请人:Pfizer Inc.
公开号:US08865706B2
公开(公告)日:2014-10-21
The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I,
and the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
本发明涉及公开的化合物,互变异构体和药物可接受的盐,其中化合物具有I式结构,变量R1和R2如规范中所定义。还公开了相应的药物组合物,治疗方法,合成方法和中间体。